Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 24 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/9/2008 First Published: 9/26/2007


1.		Phase II/III Study of Disease-Specific High-Dose Conditioning Regimens Followed by Autologous Stem Cell Transplantation (Single or Tandem) in Patients With Hematologic Malignancies or Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				4 and over				NCI				RPCI-I-72806 I 72806, NCT00536601

Last Modified: 4/21/2008 First Published: 8/24/2003


2.		Phase I/II Study of Donor Lymphocyte Infusion in Patients With Persistent, Relapsed, or Progressing Malignancy After Nonmyeloablative Allogeneic Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Any age				NCI				FHCRC-1803.00 NCT00068718

Last Modified: 9/13/2007 First Published: 1/5/2007


3.		Phase I/II Study of Paclitaxel and Ifosfamide Followed By Paclitaxel, Carboplatin, and Ifosfamide With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin-Resistant Germ Cell Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				MSKCC-06077 NCT00423852


4.		Evaluation of Single Session Stereotactic Body Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				2005-0445 NCT00492817


5.		Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				UPCC 20406 NCT00674427

Last Modified: 8/9/2007


6.		Phase II Study of Tandem High-Dose Chemotherapy with Autologous Stem Cell Rescue for Poor Prognosis Germ Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				CHNMC-96126 NCI-G97-1136, NCT00002931

Last Modified: 8/23/2008 First Published: 7/1/2001


7.		Phase II Pilot Study of High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation and Immunotherapy With Activated T Cells, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Stage IIIB or IV Breast Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				WSU-2007-033 NCT00020722, RWMC-0634246


8.		Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				Other				4T-03-1 NCT00183820

Last Modified: 9/3/2008 First Published: 4/21/2006


9.		Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UMN-2005NT018 UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932


10.		Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				0609-11 IUCRO-0166, AVF4003s, NCT00393861

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute